Ayanna Brown
Psychiatry · Kingwood, TXNPI 1114095601
Payments from drug & device makers
Across 271 payments — averaging $21.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$2K
- AbbVie$793
- Lundbeck LLC$694
- Neurocrine Biosciences, Inc.$293
- Supernus Pharmaceuticals, Inc.$237
- Corium, LLC$231
- plus $2K from 21 others
What the payments were for
- Food & beverage$5,862100%
- Education$260%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 65 | $1,599 |
| AbbVie(2 entities) | 44 | $793 |
| Lundbeck LLC | 34 | $694 |
| Neurocrine Biosciences, Inc. | 9 | $293 |
| Supernus Pharmaceuticals, Inc. | 11 | $237 |
| Corium, LLC | 13 | $231 |
| Teva Pharmaceuticals USA, Inc. | 8 | $225 |
| Sunovion Pharmaceuticals Inc. | 12 | $218 |
| Collegium Pharmaceutical, Inc. | 6 | $195 |
| Johnson & Johnson | 11 | $189 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $178 |
| Tris Pharma Inc | 7 | $165 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $124 |
| Axsome Therapeutics, Inc. | 5 | $113 |
| Shire North American Group Inc | 7 | $112 |
| Boehringer Ingelheim | 1 | $101 |
| Neos Therapeutics, LP | 5 | $95 |
| Jazz Pharmaceuticals Inc. | 3 | $55 |
| E.r. Squibb & Sons, L.L.C. | 2 | $51 |
| Ironshore Pharmaceuticals Inc. | 3 | $50 |
| Arbor Pharmaceuticals, Inc. | 3 | $43 |
| Almatica Pharma LLC | 2 | $39 |
| Alkermes, Inc. | 1 | $23 |
| OWP Pharmaceuticals, Inc. | 1 | $22 |
| Idorsia Pharmaceuticals US Inc | 1 | $17 |
| Vanda Pharmaceuticals Inc. | 1 | $15 |
| Adlon Therapeutics L.p. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- REXULTI$244
- INGREZZA$122
- ABILIFY ASIMTUFII$122
- ABILIFY MAINTENA$122
- Austedo XR$122
- JORNAY PM$120
How this compares
$5,888 in reported general payments places this provider in the 85th percentile of 2,238 psychiatry providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Paliperidone ErPaliperidone | 12 | $2,816 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 28 | $1,178 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 17 | $797 |
| Aripiprazole | 12 | $547 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 13 | $156 |
| Escitalopram Oxalate | 32 | $106 |
| Quetiapine Fumarate | 17 | $94 |
| Lamotrigine | 32 | $51 |
| Mirtazapine | 13 | $29 |
| Clonidine Hcl | 13 | $3 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Kingwood
- Scott BartleyDallas$42.7M
- David BrownAustin$15.8M
- Rajinder ShiwachDesoto$15.4M
- Darin OkudaDallas$14.7M
- Jason MensahBeaumont$10.3M
- Michael DowningDallas$7.6M
- Rakesh JainLake Jackson$7.2M
- Suresh SureddiPlano$5.9M
- Marshall LucasThe Woodlands$4.8M
- Sejal MehtaPlano$3.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.